View conference programme - The British Society for Rheumatology

SCLERODERMA (216 – 233)
216 OXIDISED LOW DENSITY LIPOPROTEIN AND HOMOCYSTEINAEMIA ARE RISK FACTORS FOR
MACROVASCULAR DISEASE IN SYSTEMIC SCLEROSIS.
M Ho 2 , AH Strang 1 , M McLaren 1 , F Daly 1 , C Eastmond 3 , G Nuki 4 , JJF Belch 1 . 1
University Department of
Medicine, Ninewells Hospital and Medical School, Dundee, United Kingdom; 2 Dept. of Rheumatology,
Northampton General Hospital NHS Trust, Northampton, United Kingdom; 3 Dept. of Rheumatology,
Aberdeen Royal Infirmary, Aberdeen, United Kingdom; 4 Rheumatic Diseases Unit, Western General
Hospital, Edinburgh, United Kingdom
217 CTGF: A POTENTIAL MARKER OF FIBROSIS IN SCLERODERMA?
M Dziadzio 1 , W Usinger 2 , H Penn 1 , C Black 1 , D Abraham 1 , C Denton 1 , R Stratton 1 . 1
Rheumatology, Royal
Free Hospital, London, United Kingdom; 2 FibroGen, San Francisco, CA, United States
218 QUALITY OF LIFE WITH LIMITED CUTANEOUS SYSTEMIC SCLEROSIS.
AE Gliddon 1 , CJ Dore 2 , PJ Maddison 3 , the Quins Trial Study Group. 1 School of Sport, Health & Exercise
Science, University of Wales, Bangor, Bangor, Gwynedd, United Kingdom; 2 MRC Clinical Trials Unit,
London, United Kingdom; 3 Rheumatology Department, Ysbyty Gwynedd Hospital, Bangor, Gwynedd,
United Kingdom
219 A PILOT STUDY ASSESSING THE RESPONSE OF SINGLE DOSE SILDENAFIL CITRATE (VIAGRA)
IN THE TREATMENT OF RAYNAUDS’ PHENOMENON IN PATIENTS WITH SYSTEMIC SCLEROSIS.
N Kumar 1 , J Allen 2 , A Murray 2 , B Griffiths 1 . 1
Department of Rheumatology, Musculoskeletal Unit,
Freeman Hospital, Newcastle-upon-Tyne, United Kingdom; 2 Regional Medical Physics Department,
Freeman Hospital, Newcastle-upon-Tyne, United Kingdom
220 PULMONARY HYPERTENSION IN SYSTEMIC SCLEROSIS - SCREENING GUIDELINES IN PRACTISE.
S Busteed, RJ Moots, RN Thompson. Rheumatology, University Hospital Aintree, Liverpool, Merseyside,
United Kingdom
221 PULMONARY ARTERIAL HYPERTENSION IN FIBROTIC AND NON-FIBROTIC SSC PATIENTS -
RESPONSE TO THERAPY.
A Kawald, M Williams, C Elliott, CM Black, GJ Coghlan. 1 Department of Academic Rheumatology, Royal
Free Hospital, London NW3 2QG, United Kingdom; 2 Department of Cardiology, Royal Free Hospial,
London NW3 2QG, United Kingdom
222 A COMPARISON OF FINGER AND EARLOBE OXIMETRY IN PATIENTS WITH SYSTEMIC SCLEROSIS.
K Isdale 1 , BR O’Driscoll 2 , AL Herrick 1 . 1
University of Manchester Rheumatic Diseases Centre, Hope
Hospital, Salford, United Kingdom; 2 Respiratory Medicine, Hope Hospital, Salford, United Kingdom
223 CALCINOSIS IN SYSTEMIC SCLEROSIS - ARE WE UNDERESTIMATING ITS PREVALENCE?
K Brennan 1 , S Jackson 2 , AL Herrick 1 . 1
University of Manchester Rheumatic Diseases Centre, Hope
Hospital, Salford, United Kingdom; 2 Radiology, Hope Hospital, Salford, United Kingdom
224 RENAL INVOLVEMENT IN INDIAN SCLERODERMA PATIENTS - A SINGLE CENTER STUDY.
R Gupta 1 , R Grover 1 , V Marwaha 1 , VK Singhal 2 . 1
Clinical Immunology & Rheumatology Service,
Department of Medicine, All India Institute of Medical Sciences, New Delhi, Delhi, India; 2 Rheumatology
Department, Army Hospital (Research & Referral), New Delhi, Delhi, India
225 MONOCYTE CHEMOATTRACTANT PROTEIN-3 (MCP-3) OVEREXPRESSION IN SCLERODERMA:
REGULATION BY TGFβ.
VH Ong, M Carulli, G Lindahl, S Xu, DJ Abraham, CM Black, CP Denton. Centre for Rheumatology, Royal
Free and University College Medical School, London, United Kingdom
226 DNA BINDING-ACTIVITY OF CCAAT-BINDING FACTOR (CBF) IS STRONGLY ENHANCED IN
ACTIVATED LUNG FIBROBLASTS FROM PATENTS WITH SYSTEMIC SCLEROSIS.
GE Lindahl 1 , X Shiwen 1 , RC Chambers 2 , CP Denton 1 , DJ Abraham 1 , CM Black 1 , GJ Laurent 2 .
1
Rheumatology, Royal Free and UCL Medical School, London, United Kingdom; 2 Centre for Respiratory
Research, Dept Medicine, UCL Medical School, London, United Kingdom
58